Today it was announced that diabetes drug-maker Novo Nordisk is dropping Paula Deen. It’s understandable that a diabetes drug-maker might not want to be linked to a spokesperson who has admitted to using the n-word. After all, blacks are twice as likely as whites to get diabetes. Keeping Deen on is like hiring Mel Gibson…